XCNQ
MOOD
Market cap900kUSD
, Last price
CAD
Name
Lucy Scientific Discovery Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
31k
-68.27%
Net income
-329k
L-3.22%
CFO
-251k
L+6.91%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders. Customers can acquire these items directly through its official e-commerce platform, doseology.com. Founded in 2019, Doseology Sciences Inc. is headquartered in Kelowna, Canada.
Key people
Chris Jackson
Chief Executive Officer, Director · since 2025
Christopher Cherry
Interim Chief Financial Officer · since 2025
Timothy Corkum
President, Chief Operating Officer · since 2025
Scott Reeves
Director · since 2021
Independent Director · since 2021
Independent Director · since 2021
Zara Kanji
Independent Director · since 2024
Independent Director · since 2021
Livio Susin
Independent Director · since 2017
Daniel Vice
Independent Director · since 2019
Headquarters & legal address
SUITE 305, 9-3151 LAKESHORE RD
KELOWNA, BC V1W 3S9
CA
KELOWNA, BC V1W 3S9
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||